Enovis (NYSE:ENOV) versus Alternate Health (OTCMKTS:AHGIF) Critical Review

Alternate Health (OTCMKTS:AHGIF) and Enovis (NYSE:ENOV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations.

Valuation and Earnings

This table compares Alternate Health and Enovis”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alternate Health	N/A	N/A	N/A	N/A	N/A
Enovis	$2.25 billion	0.62	-$1.18 billion	($20.71)	-1.16

Alternate Health has higher earnings, but lower revenue than Enovis.

Insider & Institutional Ownership

98.5% of Enovis shares are held by institutional investors. 2.7% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Alternate Health and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alternate Health	N/A	N/A	N/A
Enovis	-52.69%	8.74%	4.19%

Analyst Ratings

This is a summary of recent recommendations and price targets for Alternate Health and Enovis, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alternate Health	0	0	0	0	0.00
Enovis	1	0	7	2	3.00

Enovis has a consensus price target of $47.43, suggesting a potential upside of 97.31%. Given Enovis’ stronger consensus rating and higher possible upside, analysts clearly believe Enovis is more favorable than Alternate Health.

Volatility and Risk

Alternate Health has a beta of -279.55, suggesting that its stock price is 28,055% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500.

Summary

Enovis beats Alternate Health on 10 of the 11 factors compared between the two stocks.

About Alternate Health

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.